William Tanner

Stock Analyst at Cantor Fitzgerald

(0.86)
# 3,971
Out of 5,084 analysts
5
Total ratings
20%
Success rate
-2.35%
Average return

Stocks Rated by William Tanner

Prothena Corporation
Mar 4, 2019
Assumes: Overweight
Price Target: n/a
Current: $11.30
Upside: -
TherapeuticsMD
Aug 14, 2018
Maintains: Overweight
Price Target: $1,300$1,350
Current: $1.61
Upside: +83,844.78%
Xencor
Nov 29, 2017
Initiates: Overweight
Price Target: $33
Current: $18.05
Upside: +82.83%